 The primary objective of this study is to compare the efficacy of Induction PEG-Interferon alfa-2b PEG-Intron and Ribavirin Rebetol to standard PEG-Interferon alfa-2b PEG-Intron and Ribavirin Rebetol in patients with chronic hepatitis C. 